Wouldn't say heavily experienced using Bisantrene but they know it very well + well respected in treating AML and regularly are working on treating patients with AML. I guess to a degree the concern (Hence not a complete gamechanger) is how quickly are they moving away from Chemo treatment. As I said, they had very good things to say about this investment and that it is better than current treatments. Anymore and I will be revealing the person. My medical field is outside this scope.
RAC - Charts & Price Action, page-1450
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.55 |
Change
-0.015(0.96%) |
Mkt cap ! $257.8M | |||
| Open | High | Low | Value | Volume |
| $1.59 | $1.59 | $1.51 | $189.1K | 121.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200 | $1.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.55 | 999 | 1 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.52 |
Change
-0.015 ( 2.88 %) |
||||
| Open | High | Low | Volume | ||
| $1.55 | $1.58 | $1.51 | 7772 | ||
| Last updated 15.59pm 17/05/2024 ? | |||||
| RAC (ASX) Chart |